Welcome to our dedicated page for TIMKEN CO SEC filings (Ticker: TKR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TIMKEN CO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TIMKEN CO's regulatory disclosures and financial reporting.
Timken executive Karl Andreas Roellgen reported stock grants vesting that increased his holdings in the company. On February 8, 2026, he acquired 1,488 shares of Timken common stock at $0 per share from vesting of time-based restricted share units granted on February 8, 2024. On February 9, 2026, a further 1,244 shares vested at $0 per share from awards granted on February 9, 2023, for a total of 2,732 newly vested shares.
After these transactions, Roellgen directly owned 88,861 shares of Timken common stock, and indirectly held 4,818 shares through the TESOP plan. His reported direct holdings include 1,329 shares that were earned through dividend reinvestment in 2025.
Timken Company VP and Chief Financial Officer Michael Anthony Discenza reported routine equity compensation activity involving the company’s common stock. On February 8, 2026, 313 shares were acquired at $0 per share from the vesting of 25% of time-based restricted share units originally granted on February 8, 2024.
On the same date, 101 shares were disposed of at $104.33 per share, reflecting shares withheld to cover related tax obligations. After these transactions, Discenza directly beneficially owned 16,098 Timken common shares, including 138 shares earned through dividend reinvestment since last reported.
Timken Company officer Timothy Alan Graham reported equity transactions involving company common stock. On February 8, 2026, he acquired 388 shares at $0, reflecting the vesting of 25% of time-based restricted share units originally granted on February 8, 2024. The filing also records the disposition of 126 shares of common stock at $104.33 per share on the same date. After these transactions, Graham directly owned 9,708 Timken common shares, which include 83 shares earned through dividend reinvestment since last reported.
Timken director Richard G. Kyle reported multiple stock transactions in the company’s common stock. On February 6, 2026, he sold 30,206 shares at a weighted average price of $106.52, leaving him with 236,090 shares directly owned after that sale.
On February 8, 2026, 6,757 shares were acquired at $0, reflecting the vesting of 25% of time-based restricted share units originally granted on February 8, 2024, increasing his holdings to 242,847 shares. Also on February 8, 1,672 shares were disposed of at $104.33 in a transaction coded “F”, typically used for tax withholding, resulting in 241,175 shares directly held afterward.
Timken common stock holder files a notice to sell shares under Rule 144. The filing covers a planned sale of 2,500 shares of Timken common stock through Citigroup Global Markets on the NYSE, with an aggregate market value of $270,016.50 and 69,655,588 shares outstanding.
The shares to be sold were acquired on 02/10/2024 via restricted stock vesting from Timken as compensation for services. The notice indicates no other sales of the issuer’s securities by this person in the past three months and includes a representation that the seller is not aware of undisclosed material adverse information.
The Timken Company shareholder plans a significant stock sale under Rule 144. A notice was filed to sell 30,206 shares of Timken common stock through Vanguard Marketing Corporation on the NYSE, with an aggregate market value of $3,211,199.86, targeting an approximate sale date of February 6, 2026.
The securities to be sold were acquired on February 10, 2024 via restricted stock vesting from The Timken Company. Over the prior three months, the same seller, Richard Kyle, sold 15,837 common shares for gross proceeds of $1,283,298.86, indicating ongoing liquidation activity subject to Rule 144 limitations.
FMR LLC has filed an amended Schedule 13G reporting beneficial ownership of 2,789,718.71 shares of Timken Co common stock, representing 4.0% of the class as of 12/31/2025. Abigail P. Johnson is also listed as a reporting person with the same 4.0% beneficial interest.
The filing notes sole dispositive power over these shares and no shared voting or dispositive power. It also states the holdings are maintained in the ordinary course of business and not for the purpose of changing or influencing control of Timken.
The Timken Company filed a Form 8-K to furnish a press release announcing its results for the fourth quarter and full year of 2025. The company issued this press release on February 4, 2026 and attached it as Exhibit 99.1. On the same day, Timken plans to host a conference call and post related materials on its website, giving investors additional access to management’s discussion of the results. The company specifies that this information is being furnished, not filed, which limits how it is treated under securities law.
Timken Company’s Chief Technology Officer, John Raymond Szarka, has filed an initial Form 3 reporting his equity holdings. As of the event date, he beneficially owns 2,444 shares of Timken common stock held directly. He also holds multiple restricted share unit (RSU) awards that can settle in common stock at no exercise price, including 920, 1,725 and 1,750 performance-based RSUs tied to performance criteria over periods running from January 1, 2023 through December 31, 2027. Additional time-based RSU grants covering 168, 305, 863 and 1,175 shares vest 25% per year, with expiration dates ranging from February 10, 2026 through February 13, 2029.
Timken Company director Sarah C. Lauber reported the vesting of 400 shares of Timken common stock. The shares were acquired on January 8, 2026 at a price of $0 per share, reflecting stock that vested rather than an open-market purchase.
According to the filing, the 400 shares represent 20% of a time-based restricted share unit grant awarded on January 8, 2021. After this vesting event, Lauber directly holds 9,155 Timken common shares. This transaction reflects routine equity compensation for a board member rather than a discretionary trade in the open market.